Chinanews.com client Beijing, May 14 (Xie Yiguan) "Seeing him rise up, seeing his guests banquet, seeing his building collapse." In recent years, the financial sector has tightened supervision and many big names on the rich list have fallen into In trouble. The sentence in Kong Shangren's "Peach Blossom Fan" may be the best footnote for these bigwigs.
Liu Shaoxi, Chaoshan's "Godfather of Capital", took the lead
In November 2016, LeTV founder Jia Yueting thanked Liu Huaxi for the investment in super cars on Weibo, which mentioned Liu Shaoxi of the Yihua Group. At that time, the two people had unlimited scenery, and Jia Yueting received numerous investments.
On November 15, 2016, leaders of more than a dozen domestic famous companies such as Hailan Group, Hengxing Group, Yihua Group, Minhua Holdings, Yuyue Group, Luye Group gathered in LeTV Building, and officially signed the first An investment agreement of US $ 300 million for the first phase.
Because of participating in the operation of many listed companies, Liu Shaoxi is well-known in the local area and is known as the "Godfather of Chaoshan Capital". In Chenghai, Shantou, there is a saying that says: "Sanmo of Chenghai is dead (in dialect, it cannot be said to be dead), Xuemin, Bixiao, Liu Shaoxi."
There are many firsts in him. On August 24, 2004, Yihua Wood Co., Ltd. landed on the Shanghai Stock Exchange and became the first private company listed in Shantou. After Yihua Real Estate took the backdoor listing of S * ST Optoelectronics, it became the first listed company in the real estate industry in eastern Guangdong, and later changed its name to Yihua Health. In 2019, Liu Shaoxi ranked 531 on the Hurun Rich List with a net worth of 7.5 billion yuan.
Over time, Jia Yueting became the "first old Lai" in the 21st century due to the breaking of the capital chain. In 2020, the two subsidiaries owned by Liu Shaoxi, "Yihua Life" and "Yihua Health" successively "thunderbolt".
On April 26, Yihua Life announced that it had been investigated by the China Securities Regulatory Commission for alleged violation of laws and regulations. Yihua Life said that the company's stock may be subject to the risk of being forced to be delisted due to major violations of the law.
Yihua Life ’s net profit attributable to shareholders of its parent company in 2019 was 185 million yuan, a year-on-year decline of 147.92%. At the end of 2019, the monetary funds were only 405 million yuan, a significant decrease of 88.06% over the same period of the previous year; the balance of prepayments was 2.319 billion yuan, a substantial increase of 271.26% from the beginning of the period; the balance of short-term loans was 3.716 billion yuan, and the non-current liabilities due within one year were 2.474 billion yuan , Totaling 6.191 billion yuan.
Yihua Life's 2019 annual report was issued an audit report by Asia Pacific (Group) Certified Public Accountants, which could not express its opinion. On April 29, the Shanghai Stock Exchange also sent an inquiry letter to Yihua about the poor financial situation of his life.
Not only that, Yihua Health also suffered a huge loss of 1.8 billion yuan in 2019. Before Yihua Life was investigated, the rating agency Zhongxin International downgraded the main body of Yihua Group and two debts.
Zhongxin International believes that as of April 24, Yihua Group's headquarter has more than 5 billion yuan of bonds in the open market, and there will be great pressure on the maturity of redemption in 2020.
Data Map: Mao Amin participated in the "Hua Er and Juvenile" program.
"Mao Amin Husband" and the boss of Zhongzhi Department are in trouble
Recently, there are media reports that the Beijing Securities Regulatory Bureau will work with the Jiangsu Securities Regulatory Bureau to conduct on-site inspections on the four major wealth companies of Zhongzhi Department, Hengtian Fortune, Xinhu Fortune, Datang Fortune, and Gaosheng Fortune, to understand the true scale and Risk situation.
However, Zhongzhi Group issued a statement on the 12th that in recent days, a number of self-media and public accounts have released false information about the company, and the regulatory agency will change the general routine inspection of the company into a special investigation of the company. Reputation has a huge negative impact. The company and its subsidiaries operate in accordance with the law and regulations, and all business operations are carried out normally and orderly.
Earlier reports said that the supervisory department had asked Zhongzhi to merge the four major wealth companies to reduce space, but due to the difference in the shareholding structure of each company, the Zhongzhi Department failed to advance.
Although on the 2017 Forbes China Rich List, Jiezhi Kun ranked 116th with a net worth of 14 billion yuan. However, due to the low profile, the helm of the "Zhongzhi Department" Jiezhi Kun is well known to the outside world as "Mao Amin's husband" and "Xie Zhichun's younger brother".
Mao Amin and Jie Zhikun have two sons. Xie Zhichun was president of China Everbright Securities Co., Ltd., vice president of China Everbright Bank, deputy general manager of China Everbright (Group) Corporation and chairman of Everbright Sun Life Insurance Co., Ltd., and deputy general manager of China Investment Corporation and Central Huijin Company in 2014 General manager.
Because of this relationship, whether or not the "Zhongzhi Department" and the "China Everbright Department" have been blended has always caused market controversy. However, in May 2015, Xie Zhichun ceased to serve as the deputy general manager of CIC and said to return to his true life. Jie Zhikun's label gradually faded.
In recent years, there has been little trouble in the solution of the "trillion-level" asset empire.
Under the rectification of the financial industry, Anbang was taken over, HNA was "ischemic", and it was going to sell 500 billion yuan of assets tomorrow, and Zhongzhi Group was not spared.
In 2002, Zhongzhi Group invested in the reorganization of Zhongrong Trust. After more than ten years of development, Zhongrong Trust, CITIC Trust and Ping An Trust are ranked first in the trust industry. In 2017, Zhongrong Trust ranked second in industry revenue and fourth in profit.
However, on March 12, Jingwei Textile Machinery announced that it would acquire the 32.98% equity of Zhongrong Trust held by Zhongzhi Group through a combination of shares and cash, which also means that Zhongzhi Group has lost the actual control of Zhongrong Trust.
If we sort out the equity structure of Zhongzhi Group, Zhongrong Trust is the capital operation hub of Zhongzhi Department. Even if holding 10 listed companies and holding more than 20 listed companies, losing Zhongrong Trust will also cause huge losses for Zhongzhi Group. Therefore, Zhongrong Trust was taken over by the central enterprise, and was interpreted by the outside world as Zhong Zhi's "abandoned car and handsome."
"Chinese medicine king" Ma Xingtian and his wife's financial fraud is unprecedented
Recently, the China Securities Regulatory Commission has also focused on "Financial Fraud Professional Household" Kangmei Pharmaceutical.
"One road across the world, the two hearts are together, the wind can't take the oath, the rain can't get wet and romantic, the love can be painful and painful, and the love can lead the world to joy and joy ..." 》 The advertisement is familiar with Kangmei Pharmaceutical. It is said that the protagonist of the MV male and female characters was the love story of Kangmei Pharmaceutical founder Ma Xingtian and Xu Dongjin.
The picture shows the screenshot of "Kangmeizhilian" advertisement.
However, in reality, Kangmei Pharmaceutical may not have realized that "Yi Ji's sufferings and pains, and the world's joy and joy", at least not for investors.
On the evening of May 10, Kangmei Pharmaceutical announced that the company and executives had recently received a warning letter from the Guangdong Supervision Bureau of the China Securities Regulatory Commission. The China Securities Regulatory Commission believes that ST Kangmei ’s net profit for 2019 will be revised from -1.35 billion to -1.65 billion to -3.648 billion. The net profit has undergone significant changes after correction. The previously disclosed performance announcement related information was not accurately disclosed. The company did not disclose the performance announcement amendment announcement in a timely manner. There were violations of information disclosure.
This is after the 2017 annual report, the 2018 annual report, and the 2018 semi-annual report were "qualitatively" financially falsified, and Kangmei Pharmaceutical's annual report disclosed problems again.
In April 2019, while disclosing the 2018 annual report, Kangmei Pharmaceutical reiterated the 2017 financial statements, saying that due to errors in accounting account funds, it caused an additional 29.944 billion yuan in monetary funds, and the amount was staggering. .
After the investigation by the China Securities Regulatory Commission, more "truth" surfaced. In the past three years, Kangmei Pharmaceutical has accumulatively accumulatively increased revenue of nearly 30 billion yuan, accumulatively increased operating profit of 3.936 billion yuan, and accumulatively increased monetary funds of 88.7 billion yuan. In addition, there are suspicions of manipulating stock prices.
It is disappointing that Kangmei Pharmaceutical was once the famous "white horse stock", setting a historical record of 139 billion yuan in market value. In the past, it was said that Kangmei Pharmaceutical's tax payment accounts for one-third of Puning City and one-sixth of Jieyang City.
On the Hurun Rich List, in 2016, the Ma Xingtian family ranked 46th with 33 billion yuan of wealth; in 2018, the Ma Xingtian family ranked 52nd with 41 billion yuan of wealth; after the fraud scandal was exposed in 2019, the Ma Xingtian family fell directly To the 723rd place.
Kangmei Pharmaceutical's stocks were also subject to risk warnings. The stock abbreviation was changed from "Kangmei Pharmaceutical" to "ST Kangmei". The market value fell steeply, triggering many investors to protect their rights. Some media pointed out that Kangmei Pharmaceutical was claimed or became the largest number of claims and the largest amount of claims in the history of A shares.
According to the maximum penalty imposed by the Securities Regulatory Commission on Kangmei Pharmaceutical, Ma Xingtian and Xu Dongjin were subject to lifelong securities market bans. However, compared with Kang Dexin ’s original controller Zhong Yu, he was imprisoned for alleged misappropriation of funds and other crimes. It's much better.
After the financial fraud, Kangmei Pharmaceutical's crisis has not been lifted. The third quarterly report of 2019 shows that Kangmei Pharmaceutical's book cash is only 480 million yuan, but the bills receivable and other receivables total more than 14 billion yuan.
At the end of 2019, Kangmei Pharmaceutical and others came to "help the straw"-a syndicated loan of about 10 billion yuan. Among them, the loan interest rate is 4.275%, far lower than the previous bank loans of Kangmei Pharmaceutical. Unexpectedly, there is now a "big pit" in Kangmei Pharmaceutical's annual report.
Some netizens lamented: During the growth of private enterprises, how much sunshine they enjoy, and how much darkness they experience, perhaps an opportunity, black material is known to the world. (Finish)